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Coal is one of the most abundant and economic sources for global energy production.
However, the burning of coal is widely recognized as a significant contributor to
atmospheric particulate matter linked to deleterious respiratory impacts. Recently,
we have discovered that burning coal generates large quantities of otherwise rare
Magnéli phase titanium suboxides from TiO2 minerals naturally present in coal.
These nanoscale Magnéli phases are biologically active without photostimulation and
toxic to airway epithelial cells in vitro and to zebrafish in vivo. Here, we sought to
determine the clinical and physiological impact of pulmonary exposure to Magnéli
phases using mice as mammalian model organisms. Mice were exposed to the
most frequently found Magnéli phases, Ti6O11, at 100 parts per million (ppm) via
intratracheal administration. Local and systemic titanium concentrations, lung pathology,
and changes in airway mechanics were assessed. Additional mechanistic studies were
conducted with primary bone marrow derived macrophages. Our results indicate that
macrophages are the cell type most impacted by exposure to these nanoscale particles.
Following phagocytosis, macrophages fail to properly eliminate Magnéli phases, resulting
in increased oxidative stress, mitochondrial dysfunction, and ultimately apoptosis. In
the lungs, these nanoparticles become concentrated in macrophages, resulting in a
feedback loop of reactive oxygen species production, cell death, and the initiation of
gene expression profiles consistent with lung injury within 6 weeks of exposure. Chronic
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exposure and accumulation of Magnéli phases ultimately results in significantly reduced
lung function impacting airway resistance, compliance, and elastance. Together, these
studies demonstrate that Magnéli phases are toxic in the mammalian airway and are likely
a significant nanoscale environmental pollutant, especially in geographic regions where
coal combustion is a major contributor to atmospheric particulate matter.
Keywords: cytotoxicity, air pollution, nanoparticle, TixO2x−1, in vivo, environmental exposure
INTRODUCTION
Coal combustion is a significant component of the global energy
portfolio and accounts for approximately 30% of the world’s
overall energy needs (1). The global use of coal has continued
to increase over the last half century, especially in developing
countries, such as China and India, due in part to abundant
supplies and favorable economic factors (1). The burning of
coal on such a massive global scale has also resulted in a
range of detrimental environmental and human health concerns.
While the long-term effects of increased coal burning, such as
rising greenhouse gas emissions and climate change are clearly
a concern, the much more visible short-term consequences
associated with air pollution must also be addressed. Coal-
burning is a significant contributor to atmospheric particulate
matter with aerodynamic diameter <2.5µM (PM2.5), which is
the most concerning fraction for human health (2).
The smallest fraction of PM2.5 is ultrafine nanoscale PM
associated with air pollution. These nanoparticles have highly
significant biological impacts and can have detrimental effects
on human health (3). These mostly incidental nanomaterials
are unintentionally produced as byproducts of anthropogenic
processes and typically enter the environment shortly after
generation (4). Until recently, the majority of incidental
nanomaterials either went unnoticed or were not evaluated
for potential detrimental impacts on environmental health.
However, we now know that many of these nanomaterials
can contribute disproportionately to environmental chemistry
impacting multiple earth systems (4). Likewise, due to their
nano-scale size, these particles can readily penetrate many
of the physiological and cellular barriers used to protect
biological systems. For example, depending on size, shape,
and composition, many nanoscale particles can readily enter
the airway and gastrointestinal tract of mammals, translocate
epithelial cell barriers, access the bloodstream, and affect
the function of vital body systems (3). The convergence of
nanoscience, environmental health, and biomedical research are
beginning to provide significant insight into the impacts of
incidental nanomaterials across earth systems and in human
health (4).
As evidence of the progress being made in identifying
and characterizing new incidental nanomaterials, recent work
identified novel titanium suboxides, defined as Magnéli phases
(TixO2x−1), which are generated during coal combustion (1).
TixO2x−1 is produced during coal combustion at specific
temperatures and oxygen fugasities from stoichiometric TiO2
titanium oxide that is a common accessory mineral in nearly all
coals worldwide (1). Magnéli phases were originally discovered
during the investigation of a coal ash spill into the Dan River
(North Carolina, USA), where these novel titanium suboxides
were found downstream from the spill site (5). Magnéli phases
were observed in the size ranges of a few tens to hundreds of
nanometers and exhibit a unique electron diffraction pattern
compared to anatase and rutile, the two most common titanium
oxide minerals found in coal (5). Since the discovery of Magnéli
phases in this riverine environment, subsequent analyses of coal
ash samples from power plants throughout the United States
and China, each utilizing various types and compositions of
coal, revealed that Magnéli phases are widespread and were
present at every site tested (5). Magnéli phases were found with
compositional ranges between Ti4O7 and Ti9O17, with the most
frequent being Ti6O11 (5). Subsequent analyses of power plant
stack emissions, sludge from waste water treatment plants, and
road dust from Chinese urban areas were all found to contain
Magnéli phases (5).
Together, these data illustrate that Magnéli phases generated
as incidental nanoparticles through the combustion of coal are
widespread in the environment. However, there is currently a
paucity of data related to the in vivo relevance and physiological
effects of Magnéli phases in the mammalian respiratory system.
In the current manuscript, we demonstrate that Magnéli phases
are concentrated and ultimately sequestered in lung associated
macrophages. Magnéli phase phagocytosis significantly impairs
mitochondrial function and stimulates reactive oxygen species
(ROS) production by the macrophages. Ultimately, these trigger
pathways associated with apoptosis and lung injury. Consistent
with these findings, mice chronically exposed to Magnéli phases
demonstrate significantly decreased lung function. Together,
these data reveal the significant impact of these incidental
nanoparticles on overall respiratory function and provide further
evidence of the need for improved environmental monitoring to
screen for these and similar materials.
MATERIALS AND METHODS
Magnéli Phase Fabrication and
Characterization
Magnéli phases were synthesized using a tube furnace (diameter
= 8.9 cm) with a heating and cooling rate of 5◦C min−1 and
an N2 atmosphere (flow rate = 0.28 m
3 min−1) as previously
described (1). Heating and cooling processes were isothermal
at the target temperature for 2 hours (h). The process includes
heating pulverized coal with TiO2 nanoparticles. Magnéli phases
were produced using commercial P25 nanoparticles, which is
a mixture of the 80% anatase and 20% rutile forms of TiO2.
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Magnéli phase samples were characterized using a scanning
transmission electron microscope operating at 200 kV and
equipped with a silicon drift detector-based Energy Dispersive
X-ray Spectroscopy (EDS) system as previously described (1).
Experimental Animals
All mouse studies were approved by the respective Institutional
Animal Care and Use Committees (IACUC) at Virginia Tech
and East Carolina University, and were conducted in accordance
with the Federal NIH Guide for the Care and Use of Laboratory
Animals. All studies utilized age and gender matched wild type
C57Bl/6J mice.
Cytokine and Lactate Acid Dehydrogenase
(LDH) Assessments in Bone
Marrow-Derived Macrophages (BMDMs)
BMDMs were harvested from mice using standard protocols
(6). Briefly, harvested bone marrow cells were cultured
for 6 days in Dulbecco’s Modified Eagle Media (DMEM)
supplemented with 10% fetal bovine serum (FBS), L-Glutamine,
1× penicillin/streptomycin, and 20% L929-conditionedmedium.
After this 6-day incubation, BMDMs were re-plated at 250,000
cells/well and were allowed to adhere to the plate for
24 h. Cells were then treated with different concentrations
of Magnéli phase particles (0, 1, 10, 100, or 1,000 ppm)
overnight. Following these treatments, cell-free supernatant
was collected, and cytokine levels were assessed via enzyme-
linked immunosorbent assay (ELISA). Lipopolysaccharide (LPS)
was used at 1µg/mL as a positive control for cytokine
release. LDH activity was measured in the supernatant to
assess cytotoxicity.
Transmission Electron Microscopy to
Assess Magnéli Phase Phagocytosis
Following treatment with Magnéli phases, treatment media
was discarded and BMDMs (1 × 106 cells/well) were fixed
with 2.5% Gluteraldehyde in 0.1M Sodium Cacodylate directly
in the cell culture plate for at least 1 h. Following fixation
in 2.5% glutaraldehyde in 0.1M Na cacodylate, samples were
washed two times in 0.1M Na cacodylate for 15min each,
post-fixed in 1% OsO4 in 0.1M Na cacodylate for 1 h and
washed two times in 0.1M Na cacodylate for 10min each.
Fixative was removed and cells were dehydrated with increasing
concentrations of ethanol for 15min each as follows (15,
30, 50, 70, 95, and 100%). The dehydration was completed
with propylene oxide for 15min. The samples were then
infiltrated with a 50:50 solution of propylene oxide:Poly/Bed
812 (Polysciences Inc., Warrington, Pennsylvania, USA) for 6–
24 h followed by complete infiltration with a 100% mixture
of Poly/Bed 812 for 6–12 h. The samples were embedded in
fresh 100% Poly/Bed 812 using Beem embedding capsules
(Ted Pella Inc., Redding, California, USA) overnight. These
were then placed into a 60◦C oven for at least 48 h to cure
and harden. The embedded samples were trimmed and thin
(60–90 nm) sections were cut and collected on copper grids
(Electron Miscroscopy Sciences). These sections were stained
with aqueous uranyl acetate and lead citrate and examined
and photographed using a JOEL JEM 1400 transmission
electron microscope.
Mitochondrial Stress Test
Oxygen Consumption Rate (OCR) of BMDMs after exposure
to nanoparticles was determined using a Seahorse XF96
Extracellular Flux Analyzer (Agilent Technologies). Seahorse
96-well cell culture microplates were seeded at 100,000 cells per
well and subjected to a 24-h incubation with Magnéli phases.
Following the incubation, cells were washed with OCR assay
media (1mM pyruvate, 2mM glutamine, and 10mM glucose)
twice and then immersed in a total volume of 180 µL of media
in each well immediately before the assay. Plates were then
placed in the XF96 to establish a basal level of respiration.
Afterwards, three separate injections were performed: the
ATPase inhibitor oligomycin (1µM), the mitochondrial
uncoupler carbonilcyanide p-triflouromethoxyphenylhydrazone
(FCCP) (3µM) and the mitochondrial electron transport
chain complex III inhibitor antimycin A (2µM), respectively.
Each condition was measured three times before moving to
the next injection. Data is represented as pmol of oxygen
per minute.
Mitochondrial Membrane Potential and
ROS Assessments
Cells were grown following the conditions described above
and plated at 100,000 cells per well in black walled, clear,
flat bottom Corning Costar 96-well microplates. Images were
collected in three different channels with a 60× objective
using Hoechst 33258 (100 nM) to counterstain nuclei,
dichlorofluorescein (DCF) (100µM) to monitor reaction to
H2O2 injury, and tetramethylrhodamine, methyl ester (TMRM)
(10 nM) to assess mitochondrial membrane potential. The
following excitation/emission filters were selected to collect the
fluorescence signal for each channel on the instrument; DAPI
(Excitation 390.0 nm/18.0 nm bandpass, Emission 435.0/48.0 nm
bandpass), FITC_511 (Excitation 475.0 nm/28.0 nm bandpass,
511.0 nm/23.0 nm bandpass), Cy3 (Excitation 542.0 nm/27.0
bandpass, Emission 587.0 nm/45.0 nm bandpass), respectively.
Prior to the start of the imaging protocol, wells were treated
with TMRM and DCF for 30min, protected from light, in a
37◦C/5% CO2 incubator and washed twice with phosphate
buffered saline (PBS). Sequential images were taken in 10
fields of view for each channel in each well containing cells.
After a basal level of fluorescence was obtained for each field,
all wells were treated with 500µM H2O2 to induce injury
and a second round of images were obtained following the
same procedure. Images were analyzed in an automated
fashion using GE’s InCarta software version 1.6. Multiple
parameters were collected from each plate by creating custom
“masks” that incorporated the fluorescent target of interest.
Data are expressed as the mean pixel value under the mask
minus mean pixel value for the local background or, more
simply, Intensity-Background.
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Quantification of Titanium Concentration
in Tissues Using Inductively Coupled
Plasma Mass Spectrometry (ICP-MS)
ICP-MS analysis was performed on Agilent 7900 ICP-MS
operating in helium collision mode to reduce/remove polyatomic
interferences. Data was acquired in spectrum mode and utilized
a 3-point peak pattern for quantitative analysis. Each data point
acquisition had three replicates and utilized 250 sweeps per
replicate. Titanium levels were monitored at both 47 and 49
m/z to additionally check for potential interferences at either
value. The instrumental parameters for ICP-MS are shown in
Supplemental Figure S2A.
Scandium (45 m/z) was used as an on-line addition internal
standard. A calibration curve that ranged from 0.04 to 10
ppb titanium in solution was used to quantify titanium
in the samples according to their response ratio with the
scandium internal standard (Ti/Sc). An Anton-Parr Multiwave
GO microwave system that utilized modified Teflon (PTFE-
TFM) microwave vessels was used in the microwave digestions.
This microwave oven provides feedback from the digestion
conditions based on temperatures and whether excessive venting
was detected.
Ultrapure water was purified with a Millipore MilliQ water
purification system set at 18.2 MOhm. Single element stock
solutions of 1,000 ppm titanium (Ti) and scandium (Sc) for
ICP-MS analysis were obtained from Inorganic Ventures. Nitric
acid (67–70 w/w%) and hydrofluoric acid (47–51 w/w%) were
both trace metals grade and obtained from Fisher Scientific.
Suprapur hydrogen peroxide (30 w/w%) was also trace metals
grade and obtained fromMerck. Lung tissue samples were stored
in a freezer at −20◦C until analysis. When ready, the samples
were removed from the freezer and allowed to come to room
temperature. The entirety of the provided samples was weighed
directly into PTFE-TFM microwave vessels and ranged from
approximately 200–300 mg.
One milliliter of ultrapure water (18.2 M), 1.5mL of 70%
(w/w) nitric acid (HNO3), 0.3mL of 10% (w/w) hydrofluoric acid
(HF), and 0.2mL of 30% w/w hydrogen peroxide (H2O2) were
added to each vessel. The vessels were then capped appropriately
and loaded into the carousel of the microwave digestion system.
The samples were digested using a temperature gradient that
ramped from room temperature to 180◦C over 20min, then held
at 180◦C for 10min before cooling back to 60◦C over 10min. All
samples digested clear and colorless, with no visible particulates
in solution.
Each of the digested samples was decanted into fresh, separate
15mL polypropylene (PP) tubes, and their corresponding
digestion vessels were rinsed with 2mL of 2% (w/v) HNO3 and
decanted into their respective tubes for a 5mL total volume.
The concentrated samples were then vortexed and shaken to mix
immediately before being diluted 1:100 in 2% (w/v) HNO3 to
ensure homogeneity of the dilute samples. The 1:100 dilution
was necessary to reduce the total concentration of HF within the
samples themselves so that it did not attack the quartz portions
of the ICP-MS instrumentation.
Intratracheal (i.t.) Administration and
Imaging of Magnéli Phases in the Lung
Wild-type C57Bl/6 mice were treated with one dose of 100
ppm of Magnéli phases using i.t. administration, following
anaesthetization with isoflurane. Mice were euthanized
using CO2 and lungs were harvested 7 days following i.t.
administration. To assess chronic effects of Magnéli phases in the
lung, mice were treated i.t. with 100 ppm of Magnéli phases three
times per week. Lungs were harvested at 6 weeks after the initial
treatment. Hematoxylin and eosin (H&E) stained lung slides
were evaluated using darkfield microscopy (Cytoviva, Auburn,
AL, USA) and images were collected at a magnification of
100X. Magnéli phase localization and lung histopathology were
also evaluated by a board-certified veterinary pathologist using
H&E stained sections prepared from formalin fixed, paraffin
embedded tissues. Immunohistochemistry was conducted on
the formalin fixed, paraffin embedded tissues using an APAF1
polyclonal antibody (Invitrogen; PA5-85121) and rabbit specific
HRP/DAB (ABC) Detection IHC kit (Abcam).
Gene Expression Profiling and Pathway
Analysis
Total RNA was harvested from whole lungs using FastRNA Pro
Green Kit following manufacturer’s protocols (MP Biomedicals).
Total RNA was pooled from 3-8 individual mice per group for
RT2 Profiler PCRArray Platform (QIAgen) cDNA reaction. Gene
expression was evaluated using PAMM-212Z and PAMM-052Z
arrays (Qiagen) following manufacturer’s protocols. The gene list
for these arrays and functional categories are available through
the manufacturer (Qiagen). Ingenuity Pathways Analysis (IPA)
and the manufacturer’s array software (Qiagen) was used to
analyze gene expression data and conduct pathway analysis. IPA
data were ranked and evaluated based on z-score as previously
described by the research team (7–9).
Pulmonary Function Testing
Male C57Bl/6J mice were exposed to PBS or Magnéli phases
three times/week for 6 weeks (18 total doses). Briefly, mice
were anesthetized with isoflurane and received Magnéli phases
(100 ppm) in 50 µl by i.t. administration as described above
for the chronic exposure assessments. Pulmonary function
testing was performed 24 h following the last exposure. All
mice were anesthetized with tribromoethanol (TBE) (400
mg/kg), tracheostomized, and baseline pulmonary function was
recorded using the FlexiVent system (SCIREQ, Montreal, QC,
Canada) (10, 11).
Mice were ventilated with a tide volume of 10 ml/kg at a
frequency of 150 breaths/min and a positive end expiratory
pressure (PEEP) of 3 cm H2O to prevent alveolar collapse. In
addition, mice were paralyzed with pancuronium bromide (0.8
mg/kg) to prevent spontaneous breathing. Electrocardiogram
(EKG) was monitored for all mice to determine anesthetic depth
and potential complications that could have arisen during testing.
A deep inflation perturbation was used to maximally inflate the
lungs to a standard pressure of 30 cm H2O followed by a breath
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hold of a few seconds to establish a consistent volume history.
A snapshot perturbation maneuver consisting of a three-cycle
sinusoidal wave of inspiration and expiration to measure total
respiratory system resistance (R), dynamic compliance (C), and
elastance (E). A Quickprime-3 perturbation, which produced
a broadband frequency (0.5–19.75Hz) over 3 s, was used to
measure Newtonian resistance (Rn), which is a measure of
central airway resistance. All perturbations were performed until
three acceptable measurements with coefficient of determination
(COD) ≥0.9 were recorded in each individual subject.
After three baseline measurements of lung function using
“snapshot” and “Quickprime-3” perturbations, mice were
challenged with aerosolized saline or cumulative doses of 1.5, 3,
6, 12, and 24 mg/ml methacholine (MCh) (Sigma-Aldrich, St.
Louis, MO) generated by an ultrasonic nebulizer for 10 s without
altering the ventilation pattern (10–12). These challenges were
followed by assessments with “snapshot” and “Quickprime-3”
perturbations every 30 s. Between each dose of methacholine, a
deep inflation perturbation was initiated to reset lung hysteresis.
For each animal, all perturbations were performed until six
acceptable measurements with COD ≥0.9 were recorded.
Replicates
All studies were repeated at least three independent times
unless noted.
Statistical Analysis
Single data point comparisons were evaluated by Student’s
two-tailed t-test. Multiple comparisons were evaluated for
significance using Analysis of Variance (ANOVA) followed
by either Tukeys or Newman–Keuls post-test, as appropriate.
Graphs and statistical analyses were performed and generated
using GraphPad Prism software 8 (GraphPad, San Diego, CA).
All data are presented as mean ± the standard error of the mean
(SEM) with p ≤ 0.05 considered significant. Data shown are
representative of at least three independent studies.
RESULTS
Magnéli Phases Are Cytotoxic in Murine
Bone Marrow-Derived Macrophages
In initial toxicity studies, Magnéli phases (Ti6O11) were found
to be toxic to dechorionated zebrafish embryos at 100 ppm (1).
Thus, we chose this formulation and dose as the focus of our
subsequent studies. Utilizing previously described methods, we
generated Magnéli phases that were predominately composed
of Ti6O11 (1) (Figure 1A). The resultant nanoparticles were
confirmed by electron microscopy analysis and X-ray diffraction
patterns, as previously described (1) (Figures 1B,C). These
nanoparticles have excellent light absorption in the near-infrared,
UV, and visible light range (1). Likewise, the Magnéli phases also
display a low amount of photocatalytic activity, as previously
reported (1). The resultant nanoparticles used in our studies
ranged in size from a few tens of nm to hundreds of nm (1).
Once inhaled, nanoparticles are rapidly phagocytosed by
resident macrophages in the lungs, which represent the
predominate cell type responsible for neutralization and
clearance (13). To evaluate the effect of Magnéli phases on these
cells, we generated primary bone marrow derived macrophages
(BMDMs) using established protocols (13). The BMDMs were
treated with varying doses of Ti6O11 Magnéli phases across a 0–
1,000 ppm range and over a 24-h time course (Figures 1D–H).
Transmission electron microscopy (TEM) assessments revealed
Magnéli phases, concentrated in phagolysosomes within treated
macrophages at all concentrations and timepoints evaluated
(Figures 1D,E). Morphology assessments did not appear to show
high levels of macrophage activation following phagocytosis.
However, at 100 ppm, a significant number of macrophages
demonstrated morphology consistent with increased cell death,
specifically apoptosis (Figure 1F). Several features were noted,
including cell shrinkage, loss of membrane integrity, and
membrane blebbing (Figure 1F). To quantify cell death, we
utilized trypan blue exclusion and manual counting using a
hemacytometer. Here, we observed a dose dependent increase in
cytotoxicity between 10 and 1,000 ppm, ranging from 19.75 ±
2.63% to 44.25 ± 4.787%, respectively (Figure 1G). The average
cell death over the same 24-h time range in the mock treated
macrophages was 16.25 ± 2.062% (Figure 1G). Macrophage cell
death did not initiate immediately, requiring 24 h post-exposure
to peak (Figure 1H). Using 100 ppm, cell death was assessed over
a time course, with almost double the number of macrophages
undergoing cell death at 24 h post-exposure (15.25 ± 0.957%
mock vs. 31.25 ± 3.403% Ti6O11 Magnéli phase treatment)
(Figure 1G). Together, these data show that Ti6O11 Magnéli
phases, at levels observed in the environment as incidental
nanoparticles generated through the industrial burning of coal,
are cytotoxic to mammalian macrophages.
Nanoparticle exposure typically drives macrophage activation
and the production of inflammatory mediators (13). The cells
generated using the methods detailed here are skewed towardM1
polarized, pro-inflammatory macrophages (6). Likewise, the cell
death induced by the Magnéli phases were originally predicted to
generate damage associated molecular patterns, such as aberrant
ATP production or Calcium efflux similar to that described
for A549 cells (14), that should drive innate immune system
signaling in themacrophages. Here, wemonitored the generation
of several potent pro-inflammatory mediators, including IL-
1β, IL-6, and TNF (Figures 1I–K). Consistent with electron
microscopy findings indicating apoptosis as the method of cell
death and the lack of morphological features associated with
macrophage activation, we did not observe any statistically
significant increases in either gene transcription by rtPCR or at
the protein level by ELISA for any pro-inflammatory mediators
evaluated (Figures 1I–K). Indeed, at the gene transcription level,
we observed several mediators and transcription factors actively
down-regulated (Figure 2). These data indicate that cell death
and inflammation induced by Magnéli phases are not linked.
Despite higher levels of cytotoxicity, cell death andMagnéli phase
exposure are not sufficient to significantly activate elements of the
innate immune system associated with inflammation.
Previous studies have shown that nanoparticle phagocytosis
by macrophages can impair their function, resulting in greater
susceptibility to a myriad of pathogens (15, 16). To evaluate
macrophage functionality 24 h following either mock or Magnéli
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FIGURE 1 | Magnéli phase phagocytosis results in increased cell death in bone marrow-derived macrophages. (A–C) Characterization of Magnéli phases used in this
study. (A) Schematic illustrating Magnéli phase generation. (B,C) TEM images of Magnéli phases formed by annealing P25 TiO2 nanoparticles with coal in a pure
N2 atmosphere for 2 h at 900
◦C. Electron diffraction patterns were characteristic of Magnéli phases and confirmed these as predominately Ti6O11 particles. Particles were
(Continued)
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FIGURE 1 | between 10 and 200nm in size. (D) Un-treated bone marrow-derived macrophages (1 × 106 cells/well) and (E) macrophages treated with Ti6O11 (1, 10,
100, or 1,000 ppm) were visualized using TEM (Scale bar: 5µm). Magnéli phases appear as punctate dark dots in the macrophages and are concentrated in
phagolysosomes. (F) Macrophages containing Magnéli phases demonstrate morphological features consistent with apoptosis, including cell shrinking and membrane
blebbing (red arrows) (Scale bar: 1µm). (G,H) Cytotoxicity was evaluated using trypan blue exclusion (G) across the Ti6O11 dose range and (H) at 100 ppm over a
24 h time course. (I,J) Inflammation was evaluated by assessing the production of pro-inflammatory cytokines, such as (I) IL-1β, (J) IL-6, and (K) TNF in the cell free
supernatant following exposure to different doses of Magnéli phases. (L) Macrophage function was evaluated by assessing the ability of macrophages to phagocytose
fluorescent Escherichia coli 24 h post-exposure to 100 ppm Magnéli phases. Data are expressed as mean ± SEM (n = 3 independent experiments). **p < 0.01.
phase exposure, live cells containing nanoparticles were sorted
and co-exposed to fluorescently labeled E. coli. In macrophages
lacking the Magnéli phases, we observed a significant increase in
mean fluorescence intensity (MFI: 10,630 ± 290) compared to
those containing the nanoparticles (7,826 ± 114.2) (Figure 1L).
Thus, cells containing Magnéli phases were significantly less
efficient at bacterial phagocytosis, implying that nanoparticle
sequestration has a deleterious impact on macrophage function.
Magnéli Phase Phagocytosis Activates
Apoptosis Signaling Pathways Modulated
Through the Mitochondria
To better define mechanisms underlying Magnéli phase
cytotoxicity, we profiled gene expression and utilized Ingenuity
Pathway Analysis to decipher changes in gene networks and
pathways associated with a range of biological functions in
macrophages. BMDMs were collected 24 h post-exposure to 100
ppm Ti6O11. Total RNA was collected and gene expression was
profiled using rtPCR based gene expression arrays (Qiagen).
Changes in gene expression were defined as significant if
the change was ±2-fold different between the mock and
treated cells. Based on the pattern of gene expression changes,
apoptosis signaling was the top canonical pathway that was
significantly increased following Magnéli phase exposure
(Figure 2; Supplemental Figure S1A). Individually, there
were no clear networks or relationships identified between
the top 10 dysregulated genes (Supplemental Figure S1B).
However, analysis of the congregate gene expression patterns
and networks revealed a strong relationship between genes
associated with apoptosis signaling with a focus on mitochondria
(Figure 2A). Here, we observed significant increases in gene
expression associated with both pro-apoptotic BCL-2 family
members, specifically Bax (Figure 2A). Up-stream analysis
revealed a significant increase in p53 signaling and down-stream
analysis revealed a significant increase in Apaf1 (Figure 2A).
Consistent with these findings, Caspases-3,−6, and−9 were all
found up-regulated following Magnéli phase exposure, while
Caspase-7 was significantly downregulated (Figure 2A). We also
observed a significant up-regulation in the gene encoding ICAD,
which is associated with DNA fragmentation during apoptosis
(Figure 2A). In addition to apoptosis, pathway analysis further
revealed that inflammation and inflammatory forms of cell
death, such as necroptosis, were significantly down-regulated
following Magnéli phase exposure (Figures 2A,B). While we
realize the general limitations of utilizing gene expression data
to define cell death pathways, the data indicates significant
changes in genes associated with apoptosis pathways and is
consistent with the electron microscopy and inflammation data
(Figure 1). Beyond cell death, very few additional pathways
were found to be significantly impacted following Magnéli
phase phagocytosis at the time points and conditions evaluated
here, with a notable exception being a general downregulation
of genes associated with NF-κB signaling (Figure 2A). This
finding is consistent with the lack of inflammation and cytokine
responses observed following exposure (Figures 1I,J). To
better evaluate our findings compared to those previously
reported for TiO2 exposure, we compared our findings to gene
expression patterns associated for TiO2 in the IPA database
(Supplemental Figure S1C). In general, many of the same
pathways are altered for both Magnéli phases and TiO2,
including the down-regulation of Tnf and the up-regulation of
Ifng (Supplemental Figure S1C). However, the major difference
between Magnéli phases and TiO2 is associated with Caspase-
3/-7 regulation. Caspase-7 is down regulated in both cases; but,
Caspase-3 is significantly up-regulated following Magnéli phase
exposure and is central in the apoptosis pathways identified
(Figure 2A; Supplemental Figure S1C). This is in contrast to
the down-regulation of Caspase-3 and cell death mechanisms
previously described following TiO2 exposure (17). Together,
these data suggest that macrophage cell death induced by
Magnéli phase exposure occurs though the mitochondrial
pathway of apoptosis and is associated with the activation of
pro-apoptotic BCL-2 family members, including a potential
p53-BAX-APAF1 axis.
Magnéli Phase Exposure Results in
Significant Mitochondrial Dysfunction
Previous studies have revealed that nanoparticles can
significantly impair mitochondria function and the convergence
of signaling pathways on the mitochondria identified in the
gene expression profiling and pathway analysis together warrant
higher resolution functional assessments. We first utilized an
Agilent Seahorse XF cell mitochondrial stress test to evaluate
the oxygen consumption rate (OCR) in BMDMs treated for
24 h with either mock, 100 ppm, or 1,000 ppm Magnéli phases
(Figure 3A). At both doses, the basal respiration and the
maximal respiratory capacity (MRC) were significantly increased
in BMDMs treated with Magnéli phases compared to mock
(Figure 3A). Cells treated with 1,000 ppm of Magnéli phases
did not show the typical decline in OCR after the addition of
oligomycin (Oligo), a known ATP synthase inhibitor, indicating
an increase in proton leak in the mitochondria (Figure 3A).
Proton leak is typically associated with mitochondrial damage
and stress (18, 19). Likewise, these cells only showed a minimal
change in MRC following the addition of the proton ionophore
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FIGURE 2 | Macrophage exposure to Magnéli phases activates gene expression profiles associated with apoptosis and mitochondria dysfunction. (A) Gene
expression was evaluated using real time PCR based Superarrays (Qiagen). For each gene target on the array, fold change was calculated based on 11Ct values.
Genes found to be ±2-fold change in expression from untreated specimens were defined as significant. The resultant data was evaluated using Ingenuity Pathway
Analysis (IPA) to define pathways and global correlations between gene expression profiles and biological functions. Cell death signaling, specifically apoptosis, was
(Continued)
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FIGURE 2 | the top pathway up-regulated in the macrophages following Magnéli phase exposure. IPA further identified gene expression profiles consistent with
mitochondria dysfunction as a potential factor associated with the increased apoptosis signaling. (B) Pathways associated with inflammation and specifically
inflammation associated cell death (i.e., pyroptosis and necroptosis) were significantly down-regulated at the level of gene transcription. Either fold change in gene
expression or z-score values are displayed for each node as appropriate.
FIGURE 3 | Alterations in cellular energetics and mitochondrial membrane potential in macrophages treated with Ti6O11. (A) Oxygen consumption rate (OCR) and (B)
extracellular acidification rate (ECAR) were measured using Agilent Seahorse XF96 Analyzer in mock and Ti6O11 treated BMDMs at either 100 ppm or 1,000 ppm. (C)
Mitochondrial membrane potential was evaluated using tetramethylrhodamine (TMRM) in macrophages treated with vehicle (blue) or 100 ppm Magnéli phases (green),
with H2O2 used to induce maximum loss of membrane potential in each group. (D) Cellular oxidative stress was evaluated using dihydrodichlorofluorescein (DCF)
fluorescence. All data are expressed as mean ± SEM (n = 3/group). AU, Arbitrary Units. *p < 0.05, #p < 0.05, **p < 0.01.
FCCP (Figure 3A), which likely reflects the significant increase
in cells undergoing cell death. The BMDMs treated with
100 ppm Magnéli phases showed the most dramatic shifts,
with the highest level of basal respiration and the largest
MRC increase, following FCCP treatment (Figure 3A). The
impressive increase in MRC suggests that Magnéli phase
exposure resulted in a substantially higher reserve capacity
in BMDMs, which is also likely associated with the increased
energy demands of the cells following increased damage,
stress, and cell death. Complementing the OCR data, we also
evaluated the extracellular acidification rate (ECAR), which is
an assessment of glycolysis. While we did not observe significant
differences in ECAR following exposure to Magnéli phases
at 1,000 ppm, we did observe a significant increase following
exposure to 100 ppm (Figure 3B). These data indicate a shift
in the substrate utilization, likely due to increased cellular
metabolism in cells treated with 100 ppm Magnéli phases.
Together, these data indicate that Magnéli phase exposure results
in altered mitochondrial bioenergetics that can significantly
contribute to damage associated processes, such as reactive
Frontiers in Immunology | www.frontiersin.org 9 November 2019 | Volume 10 | Article 2714
McDaniel et al. Pulmonary Exposure to Magnéli Phases
oxygen species (ROS) generation and the activation of cell
death cascades.
Because proton leak is also a sign of mitochondrial damage
and stress, we next investigated mitochondrial membrane
potential (MMP), as decreases in MMP are associated with
mitochondrial membrane damage and changes in mitochondrial
function. The cell-permeant dye, tetramethylrhodamine
(TMRM) accumulates in active mitochondria with healthy
MMPs. A decrease in TMRM fluorescence indicates a loss
of mitochondrial membrane potential. BMDMs treated with
100 ppm Magnéli phases had significantly lower TMRM
fluorescence (86.26 ± 13.06AU) compared to mock (613.60 ±
51.89AU) (Figure 3C), indicating treatment significantly altered
mitochondrial membrane potential. The subsequent addition of
H2O2 to each sample was used as a positive control and resulted
in significant decreased TMRM fluorescence compared to basal
fluorescence in the mock treated cells, with a much smaller
decrease in the cells treated with Magnéli phases (Figure 3C).
Together, these data suggest that Magnéli phase exposure results
in a significant decrease in mitochondrial membrane potential,
and confirms severe mitochondrial membrane damage.
The production and modulation of ROS is a common
biological response in macrophages to nanoparticle exposure,
is associated with cytotoxicity, and is commonly involved in
mitochondrial stress (20–22). Increased ROS production is a
significant driver of cell death and stress following TiO2 exposure
(20). A previous study assessed ROS levels in A549 alveolar
epithelial cell lines following TiO2 and undefined Magnéli
phase exposure (14). Under the conditions evaluated, the TiOx
nanoparticles increased intracellular Ca2+ that was associated
with low levels of cytotoxicity, but no significant changes on
ROS production were observed (14). Due to the inherent
differences in nanoparticle responses between different cell types
and the potent cytotoxic effects of dysregulated ROS production,
we next evaluated this response following exposure to Ti6O11






which is oxidized by ROS into the fluorescent DCF. BMDMs
challenged with 100 ppm Magnéli phases for 24 h had a
significantly higher level of ROS production (1,105 ± 94.17)
compared to mock exposed cells (76.39 ± 7.22) (Figure 3D).
Taken together, these data suggest that macrophages treated
with Magnéli phases show increased ROS production and loss
of mitochondrial membrane potential after 24 h. All of which
are indications that these particles induce mitochondrial stress
and are consistent with the induction of mitochondria-mediated
apoptosis following Magnéli phase exposure.
Magnéli Phases Are Sequestered in
Lung-Associated Macrophages and
Concentrate in the Tissue After a Single
Exposure
In the only in vivo toxicity study conducted to date, Magnéli
phases were shown to be bioactive and toxic to zebrafish at
100 ppm (1). These studies provided the first indication that
these incidental nanoparticles could be biologically active and
potentially toxic to a variety of animal species, including humans.
However, the impact of Magnéli phases in mammals and the
mechanism of toxicity were not explored (1). Thus, we next
sought to extend these findings using mice and a respiratory
exposure model. Mice were exposed to 100 ppm Ti6O11
Magnéli phases in 1× PBS via intra-tracheal administration using
methods previously described to evaluate nanoparticle toxicity
and trafficking in the respiratory tract (13, 23). To quantify the
concentration of Magnéli phases in the lungs over time, we
utilized inductively coupled plasma mass spectrometry analysis
to detect titanium levels (Figure 4A; Supplemental Figure S2A).
Immediately following i.t. administration, tissues including the
lungs, liver, spleen, and kidneys were removed, digested, and
processed for ICP-MS. These data represent the maximum
deposition control (Figure 4). As expected, no titanium was
detected in tissues outside of the lungs or in any tissues that were
not exposed to the Magnéli phases. However, in exposed lungs,
we observed 14.46 ± 4.32µg/g of lung tissue immediately after
deposition (Figure 4A). Within 24 h post-exposure, titanium
levels detected in the lungs dropped to 3.40 ± 1.19µg/g of
lung tissue (Figure 4A). However, surprisingly, after this single
exposure to the Ti6O11 Magnéli phases, the levels of titanium
in the lungs were maintained over the course of a week with
levels holding steady at 5.30 ± 1.23µg/g (Day 3) and 5.91 ±
1.30µg/g (Day 7) (Figure 4A). Titanium levels were below the
level of detection in all of the other tissues evaluated at the time
points assessed (Supplemental Figure S2B). Together, these data
emphasize the potential consequences of even a single exposure
to Magnéli phases, which are retained in the lungs at significant
levels for an extended duration following inhalation.
We next sought to identify where in the lungs the
Magnéli phases were being sequestered. We initially utilized
histopathology assessments of H&E stained lung sections to
evaluate both nanoparticle deposition and pathology. Lungs
were fixed by gravity inflation with formalin and paraffin
embedded for staining as previously described (13, 23).
Lung pathology was evaluated by a board-certified veterinary
pathologist (S.C.O.). Control mice received either vehicle or
were challenged with a 1 mg/ml dose of LPS (Figures 4B,C).
As anticipated, lung histopathology was normal in the vehicle
treated animals (Figure 4B). Conversely, we observed significant
airway inflammation in the LPS treated animals, characterized
by predominately macrophage and neutrophil infiltration
concentrated around the airways and vasculature (Figure 4C). In
the experimental animal groups, we did not observe significant
evidence of inflammation in the mice exposed to Magnéli
phases at 1, 3, or 7 days post-exposure (Figure 4D). However,
Magnéli phases were readily observed as punctate foci within
cells in the lungs under light microscopy conditions (Figure 4D).
Further assessments at higher magnification revealed that
the vast majority of Magnéli phases were sequestered in
macrophages, with no nanoparticles observed under light
microscopy conditions associated with or within any other cell
type in the lung or observed in the vehicle control specimens
(Figures 4B,D). To confirm the association of Magnéli phases
with the macrophages in the lungs, we conducted enhanced
darkfield microscopy (Cytoviva) (Figures 4E–G). A reference
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FIGURE 4 | Magnéli phases concentrate in pulmonary macrophages following a single exposure and are retained in the lung. (A) Following a single airway exposure
to 100 ppm, titanium associated with the Magnéli phases were retained in the lungs and detected using ICP-MS for over 7 days post-expsure. Control tissues were
collected from animals exposed to 100 ppm Ti6O11 and immediately euthanized. (B–D) Representative H&E stained tissue sections used for histopathology
evaluation. (B) Vehicle control showing no nanoparticles or pathology. (C) Significant airway inflammation was observed in LPS treated animals, but no evidence of
inflammation was found in the mice treated with Magnéli phases at any timepoint evaluated. (D) Larges areas of macrophages containing Magnéli phases were found
in all treated animals (yellow box). (E–G) The majority of pulmonary macrophages contain Magnéli phases, with no other cell types appearing to contain or associate
with the nanoparticles determined using dark field microscopy. Darkfield images were taken of (E) Ti6O11 nanoparticles alone or the lungs of mice 7 days
post-exposure to either (F) PBS or (G) 100 ppm Magnéli phases. (G) Particles in the tissues were identified by bright punctate dots, almost exclusively localized in
macrophages. Representative H&E stained lung sections (Scale bar = 50µm). All data are expressed as mean ± SEM (n = 7/group). **p < 0.01.
image of Magnéli phases was generated and used to identify
the nanoparticles in vivo (Figure 4E). As anticipated, we did
not detect any Magnéli phases in the vehicle control specimens
(PBS) (Figure 4F). However, consistent with our pathology
assessments, Magnéli phases were confirmed in macrophages
throughout the lungs and were readily identified by their
distinctive punctate staining (Figure 4G; green arrow). Together,
these data show that Magnéli phases are effectively phagocytosed
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by lung-associated macrophages; however, the nanoparticles are
not effectively cleared from the tissue, remaining at steady levels
over the course of at least 7 days following a single exposure.
Based on our ex vivo findings that Magnéli phases are
cytotoxic, we next evaluated the in vivo impact of nanoparticle
sequestration on macrophages and lung tissue. Bronchoalveolar
lavage fluid (BALF) was collected following euthanasia and
cellularity was evaluated following differential staining. In both
the PBS and Magnéli phase treated specimens, macrophages
were the dominate population of cells recovered (Figure 5A).
FIGURE 5 | Magnéli phases concentrate in pulmonary macrophages, resulting in significant dysfunction. (A) Representative images of BALF cytology from PBS and
Ti6O11 (100 ppm) treated mice. (B) Differential cell counts in the BALF after treatment with PBS, Ti6O11, or LPS. (C) Gene expression profiling and analysis using
Ingenuity Pathway Analysis software identified gene transcription patterns associated with increases in apoptosis, formation of reactive oxygen species, and wound
healing/fibrosis. Data are expressed as mean ± SEM (n = 3 mice per PBS treated group, n = 7 mice per Ti6O11 treated group, and n = 4 per LPS treated group).
*p < 0.05.
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This is in contrast to the highly inflammatory conditions
observed following LPS treatment (data not shown) or following
exposure to nanoparticles with immunostimulatory properties,
where neutrophils are the dominate cell type observed (24–27).
Magnéli phases were readily identified in macrophages collected
from the lungs of exposed mice at all time points evaluated,
with 71 ± 10.16% of the macrophages containing at least 1
readily observable nanoparticle under 40× light microscopy
(Figure 5A). Consistent with our in vitro cytotoxicity data, many
of the macrophages recovered from the airways demonstrated
morphological features consistent with cellular stress and death
(Figure 5A). The cell populations recovered in the BALF
were further quantified using a hemocytometer (Figure 5B).
Macrophages, neutrophils, and lymphocytes were recovered in
the BALF from mice exposed to either PBS or Magnéli phases
(Figure 5B). The quantity and populations of cells recovered
in BALF are routinely utilized as surrogates to characterize
lung inflammation (28). Compared to findings commonly
reported following exposure to immunostimulatory agents,
such as LPS, and consistent with the pathology evaluations
shown in Figures 4B–D, the number and populations of cells
recovered following exposure to Magnéli phases indicate that
these nanoparticles do not induce significant lung inflammation
(Figure 5B). Indeed, assessments of inflammatory mediator
levels, such as IL-6, in the BALF following either Magnéli
phase exposure or LPS exposure, further confirm these findings
(Supplemental Figure S3A). Consistent with the increased
cytotoxicity, we observed a significant decrease in the number
of macrophages recovered in the BALF from mice exposed to
Magnéli phases (Figure 5B). No other cell populations appeared
to be impacted (Figure 5B). Together, these data indicate that
airway exposure to a single dose of Magnéli phases at a range
previously found in environmental samples following incidental
nanoparticle release and cytotoxic to zebrafish embryos indeed
facilitates macrophage cell death in the mammalian lung.
Consistent with the apoptosis findings (shown in Figures 1,
2), neither in vivo macrophage cell death nor exposure to the
Magnéli phases result in significant inflammation.
To better define the mechanisms underlying the in vivo
response to Magnéli phase exposure, lung tissue was collected
7 days post-exposure. Total RNA was isolated and processed
for gene expression profiling using the SuperArray platform
and IPA, as previously described (7–9). The gene expression
profiling analysis revealed significant changes in several pathways
associated with cell death and lung function. The three top
pathways predicted by IPA analysis to be significantly activated
7 days post-exposure to the Magnéli phases were (1) apoptosis—
specifically apoptosis of monocytes; (2) formation of ROS;
and (3) fibrosis. In all three cases the combination of genes
up-regulated and down-regulated were predicted to have an
activating effect on the pathways identified (Figure 5C). Also, of
note, no pathways were predicted to be significantly inhibited
based on the gene expression patterns evaluated and no pathways
associated with inflammation were significantly modulated
following Magnéli phase exposure. The predicted activation of
apoptosis of monocytes and formation of ROS in vivo are highly
consistent with the findings from our in vitro studies and further
emphasize the detrimental impact that the Magnéli phases are
having on the macrophage populations in the lungs following
exposure. The fibrosis gene expression signature is intriguing.
The 7-day timeframe of the exposure model is far too soon for
lung fibrosis to present in the mice and no pathologic features
associated with fibrosis were detected in our specimens by
histopathology, collagen, or fibronectin assessments (Figure 4).
It is possible that we are identifying gene signatures associated
with fibrosis at a very early time in the lungs, prior to pathological
disease onset. However, this gene expression pattern would also
be consistent with increased regeneration and repair processes in
the lungs, perhaps associated with the increased cell death.
Repeated Exposure to Magnéli Phases
Results in Significant Nanoparticle
Accumulation in the Lungs
In most cases of incidental nanoparticle release into the
environment, biological exposure to Magnéli phases are expected
to occur repeatedly and for an extended duration. Thus, we
next sought to determine the impact of chronic airway exposure
to the Ti6O11 nanoparticles over a 30-day time period. Under
these conditions, we observed a significant increase in titanium
concentrations in the lungs, which accumulated to levels that
were ∼6-fold higher (35.82µg/g of lung) than levels observed
after a single exposure (5.92µg/g of lung) (Figure 6A). Similar to
the findings from the single exposures, pathology assessments of
the lungs again revealed that the majority of the Magnéli phases
detectable under bright-field microscopy were sequestered in
lung-associated macrophages (Figure 6B). Despite the increased
concentrations of nanoparticles in the lungs, we did not
observe any pathologic features associated with increased
inflammation or differences in pro-inflammatory mediators,
such as IL-6, IL-1β, or TNF levels, in the lungs (Figure 6B;
Supplemental Figures S3A–F). Pathology assessments revealed
no evidence of interactions with other cell types beyond
the macrophages under bright-field microscopy. To better
define nanoparticle-cell interactions, we evaluated specimens
using enhanced dark field microscopy (Cytoviva) (Figure 6C).
Consistent with our bright field data and similar to what we
observed following the single exposure, the Magnéli phases
are overwhelmingly concentrated in macrophages in the lung
(Figure 6C). It should be noted that we did identify punctate
staining associated with alveolar epithelial cells, indicating that
under chronic exposure conditions, there are some interactions
between other cell types in the lungs and the Ti6O11 nanoparticles
(Figure 6C). However, compared to the macrophages, Magnéli
phase interactions with these cells were more sporadic and
involved far fewer nanoparticles per cell (Figure 6C). Using cells
recovered following BALF and evaluated following differential
staining assessments, the number of macrophages containing
Magnéli phases per 100 cells was determined and used to generate
a phagocytic index (29). Following the single exposure toMagnéli
phases, we calculated the phagocytic index to be 71.14 ± 3.84 on
day 7, with the majority of macrophages recovered containing
>1 nanoparticle per cell (Figure 6D). However, following the
multiple exposures, the phagocytic index significantly increased
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FIGURE 6 | Repeated exposures concentrates Magnéli phases in pulmonary macrophages. (A) Using ICP-MS, we quantified the amount of titanium in the lungs
following multiple airway exposures to 100 ppm Ti6O11 over a 30 day period. (B) Histopathology using H&E stained tissue sections reveled significant airway
inflammation LPS treated animals, but no evidence of inflammation in the mice treated with Magnéli phases. Larges areas of macrophages containing Magnéli
phases were found in all treated animals (Scale bar= 20µm). (C)Darkfield images were taken of mouse lungs post-repeated exposures, on day 30. Particles in the tissues
(Continued)
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FIGURE 6 | were identified by bright punctate dots. Almost all particles were concentrated in macrophages (green arrows). However, small numbers of Ti6O11
nanoparticles were found associated with alveolar epithelial cells (green arrows). Representative H&E stained lung sections (Scale bar = 50µm). (D) Phagocytic Index
(number of BALF macrophages containing Magnéli phases per 100 cells). (E–G) APAF1 immunohistochemistry staining from (E) saline, (F) LPS, and (G) Magnéli
Phase exposed lungs. (G) Following Magnéli Phase exposure, only endothelial cells and macrophages containing particles were broadly positive for APAF1. (E) In
saline exposed mice, only endothelial cells were positive for APAF1; (F) whereas, LPS exposure resulted in a range of cell types staining positive for APAF1.
Macrophages in each image are identified by red arrows. All data are expressed as mean ± SEM (n = 7/group). **p < 0.01.
to 91.00 ± 2.17 on day 30, again with almost all macrophages
recovered containing >1 nanoparticle per cell (Figure 6D).
Together, these data are consistent with the Magnéli phases
being sequestered in the macrophages. Following cell death,
the nanoparticles likely continue to concentrate in the lungs
as cells undergoing apoptosis and associated debris (including
the Magnéli phases) are further phagocytosed by additional
macrophages, creating a positive feedback loop.
Our gene expression profiling data indicated that this
sequestration resulted in apoptosis. To further evaluate this,
we conducted immunohistochemistry targeting APAF1, which
is an important mediator in mitochondria mediated apoptosis
and was significantly up-regulated at the gene expression
level (Figure 2A). Immunohistochemistry revealed that Ti6O11
treatment resulted in significant increases in APAF1+ cells in
the lungs. Consistent with previous data, endothelial cells have
high levels of APAF1+ staining, which was observed in the Saline
treated animals (Figure 6E). However, we did not observe any
significant staining in other cell types, including macrophages
(Figure 6E). In LPS treated lungs, we observed robust staining
in multiple cell types in the lungs, including endothelial
cells, epithelial cells, macrophages, and neutrophils (Figure 6G).
However, in the Magnéli phase treated animals, we did not
observe the same level of widespread staining (Figure 6F).
Rather, the APAF+ cells were predominately limited to the
endothelial cells and macrophages containing Magnéli phases
(Figure 6F). Also, of note, only the macrophages containing
Magnélli phases were APAF+. Together, these data are consistent
with our other findings localizing the in vivo effects of the
Magnélli phases to the macrophage compartment in the lungs.
Magnéli Phase Exposure Attenuates Lung
Function and Impacts Airway
Pathophysiology
Based on the data above, we predicted that exposure to Magnéli
phases would negatively impact mammalian lung function.
To directly test this hypothesis, we determined the impact
of multiple exposures of Ti6O11 nanoparticles over a 30 day
period of time on basal airflow and airway mechanics utilizing
a computer-controlled small-animal ventilator with highly
sensitive pressure transducers (Flexivent) to quantify airway
opening pressures, volume, and airflow (10, 11). In addition
to basal measurements, we also determined whether exposure
to these Magnéli phases modulates lung pathophysiology and
airway mechanics following exposure to the bronchoconstricting
agent methacholine. To evaluate airway mechanics, a snapshot
perturbation maneuver that consisted of a three-cycle sinusoidal
wave of inspiration and expiration was used to measure total
respiratory system resistance (R), dynamic compliance (C), and
elastance (E). A Quickprime-3 perturbation, which produced
a broadband frequency (0.5–19.75Hz) over 3 s, was used to
measure Newtonian resistance (Rn), which is ameasure of central
airway resistance. For the methacholine studies, after three
baseline measurements of lung function, mice were challenged
with aerosolized saline or increasing doses of 1.5, 3, 6, 12,
and 24 mg/ml of methacholine, generated by an ultrasonic
nebulizer for 10 s without altering the ventilation pattern,
followed by assessments every 30 s (30, 31). Between each dose of
methacholine, a deep inflation perturbation was initiated to reset
lung hysteresis.
Consistent with our hypothesis, exposure to Magnéli
phases resulted in significant increases in basal resistance and
Newtonian resistance (Figures 7A,B). These data indicate
that the accumulation of Ti6O11 nanoparticles significantly
attenuates baseline lung function. The increased basal resistance
and Newtonian resistance suggests that the airway diameter
and lung volumes are reduced under baseline conditions. We
also observed an increase in basal elastance and the converse
decrease in compliance (Figures 7C,D). These findings reflect
defects in alveolar and elastic tissue in the lungs and indicate
that exposure to Magnéli phases results in increased lung
stiffness and reduced lung expansion abilities. Beyond baseline
assessments, we also sought to evaluate lung function following
methacholine challenge, which is commonly used to induce
smooth muscle constriction in the lungs. Despite the increased
baseline resistance and Newtonian resistance, the lungs of mice
exposed to Magnéli phases showed minimal increases in airway
constriction following methacholine challenge (Figures 7E,F).
This is in contrast to the unexposed animals, which demonstrated
the anticipated dose dependent increases (Figures 7E,F). These
data indicate that the lungs of these mice lack the capacity to
properly function and are likely at maximum for resistance and
Newtonian resistance. Methacholine challenge also results in
increased elastance and decreased compliance in untreated mice
(Figures 7G,H). However, similar to the resistance measures,
Magnéli phase exposure resulted in minimal changes in elastance
and dynamic compliance, indicating a stiffening of the lungs
(Figures 7G,H). Together, these data are consistent with Magnéli
phase exposure resulting in significant detrimental changes in
lung mechanics and function.
DISCUSSION
In initial toxicity studies, Magnéli phases (Ti6O11) were found
to be toxic to dechorionated zebrafish embryos at 100 ppm,
without concurrent solar radiation (1). This is in contrast
to TiO2 nanoparticles, which are photocatalytically active and
toxic at the same concentrations in conditions where solar
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FIGURE 7 | Chronic exposure to Magnéli phases significantly attenuates lung function. (A–D) Baseline pulmonary function parameters including (A) total respiratory
system resistance (R), (B) Newtonian resistance (Rn), (C) elastance (E), and (D) dynamic compliance (C) were measured by FlexiVent in control and Ti6O11 exposed
mice. (E–H) Assessment of AHR to methacholine (MCh) in control and Ti6O11 exposed mice. (E) Total respiratory system resistance (R), (F) Newtonian resistance
(Rn), (G) elastance (E), and (H) dynamic compliance (C) dose response curves following challenge with increasing concentrations of MCh in aerosolized saline (0, 1.5,
3, 6, 12, and 24 mg/ml) for control and Ti6O11 exposed mice were examined on FlexiVent. All data are expressed as mean ± SEM (n = 7/group). *p < 0.05, ****p <
0.0001, compared to the PBS treated control group.
radiation is present (1). Themechanism of cytotoxicity associated
with TiO2 has previously been associated with the increase
in ROS generation (32, 33). Prior to data presented in the
current study, the physiological impact in mammalian cells and
cytotoxicity mechanisms associated with Magnéli phases were
unclear. To date, only one additional study has explored the
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cytotoxicity of these nanoparticles in mammalian cells (14). The
cytotoxicity of three different Magnéli phases and two different
TiO2 formulations were evaluated utilizing A549 cells, which are
a human lung alveolar epithelial cell line (14). In these studies,
rather than using specific formulations of Magnéli phases, the
nanoparticles were evaluated based on size, ranging from 192
to 795 nm in average diameter (14). In the A549 cells, the
TiOx Magnéli phases demonstrated low levels of cytotoxicity in
some of the size ranges evaluated and increased intracellular
Ca2+, but no significant changes in ROS levels were observed
(14). Thus, the authors concluded that in A549 cells Magnéli
phases had either similar or reduced cytotoxicity compared to
TiO2 nanoparticles with cell death associated with different
mechanisms related to Ca2+ flux (14).
The prior studies using zebrafish embryos also provides
critical insight into general in vivo toxicity and immediate
relevance to aquatic organism exposure (1). However, the impact
of Magnéli phases on other terrestrial biological systems and the
extension of these findings to human physiology is somewhat
limited. Similarly, the in vitro studies using the A549 model
provides important insight related to the interaction of Magnéli
phases with a human alveolar epithelial cell line and a comparison
with TiO2 nanoparticles (14). However, while the A549 cells are
certainly relevant, when nanoparticles are internalized through
the airway, several other cell types beyond the alveolar epithelial
cells are arguably more critical to the host response (13). Based
on data presented here, interactions between Magnéli phases and
alveolar epithelial cells appear quite limited in vivo. Our data
indicates that the vast majority of nanoparticles are sequestered
in lung-associated macrophages. These cells are the primary
phagocytic cell in the airway and these findings are similar to
other studies evaluating nanoparticle deposition in the lungs (13,
23, 24). Likewise, our data indicates that the macrophages are not
able to effectively breakdown and clear the concentrated Magnéli
phases from the lungs. Even more concerning, this sequestration
occurs even after a single challenge and suggests that even short
term, low dose exposure to Magnéli phases may pose a potential
health risk.
Once phagocytosed by macrophages, our data reveals that
Ti6O11 Magnéli phases are cytotoxic and induce apoptosis, which
is considered a non-inflammatory form of cell death. This finding
is consistent with the lack of inflammatory signaling in the ex vivo
primary macrophages and in vivo findings. However, the lack of
inflammation, both in vitro and in vivo, following nanoparticle
exposure was quite unexpected. As discussed above, we observed
active suppression of gene expression pathways associated with
necroptosis (Figure 2B), which is a proinflammatory form of
cell death. While this was also unexpected, similar findings have
been reported for other metal-based nanoparticles. Indeed, the
ability to attenuate inflammation while inducing cell death is a
favorable characteristic for engineered nanomaterials generated
for biomedical and therapeutic applications. For example, zinc
oxide nanoparticles induce high levels of apoptosis associated
with increased ROS production and significant depletion of
glutathione in human pulmonary adenocarcinoma cell lines and
have well defined anti-inflammatory activities (34, 35). Thus, it
is tempting to speculate a similar model applies to the Magnéli
phases evaluated here. Similarly, silver nanoparticles have shown
effects in neutrophils that are consistent to those described here
for the Magnéli phases in macrophages (36). Silver nanoparticle
exposure triggers activation and maturation in specific subsets
of neutrophils, followed by increased levels of IL-8 (36).
However, classical pro-inflammatory pathway activation, overall
inflammation and necrotic cell death are significantly attenuated
following exposure (36). The implication of these data indicate
that silver nanoparticles stimulate neutrophil up-take as the cell
attempts to minimize inflammation and stimulate nanoparticle
clearance (36). It is possible that a similar mechanism is also
occurring in macrophages, where Magnéli phase nanoparticle
phagocytosis is occurring, but the cells are not able to effectively
degrade or clear the nanoparticles.
Mitochondria are critical in the activation of apoptosis in
mammalian cells and the Bcl-2 family is central in the regulation
of these processes (37). Our data reveals that this pathway is
significantly dysregulated following Magnéli phase exposure and
provides insight into the mechanism underlying the increased
apoptosis observed following nanoparticle exposure. These
data are consistent with findings associated with a diverse
range of metal-based nanoparticles. For example, gadolinium
oxide (Gd2O3) nanoparticles have been shown to induce
apoptosis through dysregulation of BCL2/BAX signaling and
ROS production in response to DNA damage in human
neuronal cells (38). Likewise, similar to the gene expression
pattern observed following Magnéli phase exposure, silver
nanoparticle exposure also increases caspase 3, Bax, and P53
expression, increased ROS signaling, and apoptosis in the MCF-
7 human adenocarcinoma cell line (39). But, as discussed
above and also similar to Magnéli phases, silver nanoparticle
exposure results in an attenuated immune system response
(36). Interestingly, lower doses of Magneli phases (100 ppm)
increased maximal respiration, consistent with the concept of
mitochondrial hormesis, whereby ROS upregulate mitochondria
as a compensatory mechanism to fight cellular stressors (40).
This is consistent with our observation that higher doses (1,000
ppm) were associated with functional decrements, including
uncoupled respiration and a loss in respiratory reserve in
macrophages. Likewise, the dramatic shifts observed in the OCR
and ECAR at 100 ppm further emphasize that the mitochondria
are dysfunctional and indicates that Magnéli phase exposure
results in significantly altered mitochondrial bioenergetics. This
likely contributes to damage associated processes, such as ROS
generation and the activation of cell death cascades. Together,
these data support a model whereby Magnéli phases directly
impair mitochondrial function following exposure and induce
cell death in macrophages through the mitochondrial-mediated
intrinsic apoptosis pathway.
Despite the lack of inflammation in the lungs following
Magnéli phase exposure, it is clear that the sequestration and
concentration of these nanoparticles and resultant macrophage
cell death significantly affects lung function. We observed
significant changes in resistance, compliance, and elastance at
baseline and following methacholine stimulation (Figure 7).
At baseline, the increase in resistance following repeated
Magnéli phase exposure reflects a narrowing of the central and
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conducting airways, including the trachea, bronchi, bronchioles,
and terminal bronchioles. Similarly, the reduction in compliance
and corresponding increase in elastance at baseline reflect
the need for greater pressures to increase lung volume in
animals exposed to Magnéli phases. Following stimulation with
methacholine, we observed predicted changes in R, Rn, E,
and C in animals unexposed to Magnéli phases, reflecting
normal lung function. However, in mice exposed to the
nanoparticles, we observed relatively minimal changes in lung
mechanics from baseline (Figure 7). This suggests that the lungs
have already reached their near maximum potential for the
parameters assessed in this study. Together, these consequential
alterations in airway mechanics indicate that the lungs of
mice exposed to Ti6O11 Magnéli phases are significantly stiffer
and more constricted compared to unexposed animals. This
influences both baseline lung function and normal airway
contractility following stimulation. These findings are consistent
with restrictive lung disease and are similar to findings reported
for silica associated models of fibrosis, which are characterized
by low levels of inflammation and the production of pro-
fibrotic growth factors that ultimately result in fibrotic lesions
due to diminished lung clearance of the silica particles (41–44).
These fibrotic lesions are directly associated with diminished
macrophage function. Macrophages that concentrate the silica
particles are highly effective in directly stimulating fibrogenesis
associated growth factors in the lungs that can impair lung
function. These findings are consistent with those presented
here following exposure to Magnélli phases and we speculate
that a similar mechanism underlies the observed decrease in
lung function.
Due to the widespread environmental distribution of
incidental Magnéli phases in the air and water associated
with global coal combustion, it is critical that we have a
better understanding of their biological impacts. Improved
understanding of the dynamics associated with nanoparticle
physicochemistry, cellular, and organismal responses following
exposure, environmental transport, and global distribution
patterns are all critical for providing a basis for establishing
future frameworks to determine potential risks to human health
and inform environmental policy decisions. Our findings here
are highly cautionary, as a single exposure to Magnéli phases
can result in potentially harmful long-term health effects.
Unfortunately, there is currently no practical way to limit the
formation of Magnéli phases and other nanoparticle formation
during the coal burning process. However, in countries with
strong environmental regulations, most of these nanoparticles
can be captured by particle traps prior to final emission of exhaust
gas. While we have provided the first evidence of the detrimental
impacts of Magnéli phase exposure in mammals, it is clear that
further toxicology studies are necessary and future assessments of
the impact of these nanoparticles on human health is warranted.
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Supplemental Figure S1 | Apoptosis signaling was significantly increased in
macrophages following exposure to Magnéli phases. (A) IPA revealed that cell
death and apoptosis signaling pathways were significantly up-regulated following
Ti6O11 exposure. The top molecular and cellular functions predicted to be
impacted by exposure were associated with cell death, cellular function and
maintenance, DNA repair, and cellular organization. (B) The 10 genes most
impacted (the top 5 up-regulated and down-regulated) by Magnéli phase
exposure in macrophages have broad and diverse biological functions. (C)
Macrophage responses to Magnéli phases produce a gene expression pattern
similar to that observed following exposure and activation following titanium
dioxide. However, Magnéli phase exposure is significantly less inflammatory (lower
levels of IFNG, IGF1, and FASLG), while inducing higher levels of apoptosis and
increased mitochondria dysfunction. The activation of gene networks associated
with Caspase 3 is a significant difference observed here for Magnéli phases, which
is down-regulated following titanium dioxide exposure.
Supplemental Figure S2 | Titanium was not found in tissues and organs outside
of the lungs. (A) Table showing ICP-MS instrument parameters used for the
detection of titanium in tissue. (B) Blood, liver, and kidneys were evaluated for
titanium levels over the course of 7 days post-exposure to a single dose of Magnéli
phases at 100 ppm. All levels in all tissues were below the level of detection, with
the exception of a single liver sample, shown here 3 days post-exposure.
Supplemental Figure S3 | Magnéli phases are non-inflammatory. (A,B)
Pro-inflammatory cytokine levels were evaluated by gene expression using rtPCR
and protein evaluations using ELISA in all in vitro and in vivo studies. However, no
significant increases in the majority of potent pro-inflammatory mediators were
detected. (A–F) IL-6, IL-1β, and TNF levels were evaluated in bronchoalveolar
lavage fluid (BALF) by ELISA following either (A–C) a single exposure of 100 ppm;
(D–F) chronic exposures of 100 ppm Magnéli phases; or (A–F) airway exposure to
1 mg/ml of lipopolysaccharide (LPS). LPS induced a robust IL-6, IL-1β, and TNF
response; however, no exposures to the Magnéli phases significantly induced
these proinflammatory mediators. ∗p < 0.05.
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